Jazz Pharmaceuticals (NASDAQ:JAZZ) is a biopharmaceutical company focused on developing and commercializing innovative medicines to address unmet medical needs in various therapeutic areas, including sleep disorders and oncology. It has a diverse portfolio of marketed products, along with a dynamic pipeline of potential therapies in various stages of development. The company aims to transform the lives of patients by creating and offering options for complex healthcare challenges. Jazz Pharmaceuticals is committed to achieving these objectives through its dedication to innovation, collaborative research, and compassionate patient care.